Nanomedicine Lab welcomes new talent to strengthen neurotechnology efforts

We are pleased to share that Dr. Clémentine Quintana has joined our team as a Preclinical Research Scientist. Clémentine is a neurobiologist and neuroscientist, studied at the Université de Montpellier 2 in France and completed her PhD at the University of Toronto at the laboratory of Prof. Jean Martin Beaulieu (Canada Research Chair in Molecular Psychiatry). She has a passion for bridging fundamental neuroscience research and preclinical innovation. In the Nanomedicine Lab she will be working on the integration of conformable electronic devices based on 2D nanomaterials interfacing with the living brain tissue for monitoring, diagnostic and therapeutic purposes, as part of the Skin2DTronics project (ERC Synergy Grant).
Welcome Clémentine!